Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Filament Health Corp N.FH


Primary Symbol: FLHLF

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.


GREY:FLHLF - Post by User

User Avatar Image
(56)
•••
  • dothemathpeopleX
Post by dothemathpeopleon May 07, 2024 9:06am
210 Views
Post# 36026551

Too many geniuses,

Too many geniuses,Not enough smart people.  This company should be doing much better than they are.  Talk about being lost in a space.

They need a market savy, experienced equity guy/gal in house.  It seems clear that they do not know WTF they are doing market side.  And I do NOT mean hiring some market maker/PR BS band aid hire or reatainer like SH or EC or AC or any of the other usual suspects.

I mean a guy/gal, full time, who looks after all things market side, internally.  Do a full run down of the business and what the needs are going forward, including capex strategy.  Then do a financing the right way.

i am sure they have gone down that road, but it looks bumpy.  Needs some smoothing.

Operationally, I guess we will wait for their financials to tell the tale.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities